What's new

Human medicines European public assessment report (EPAR): Zyprexa, olanzapine, Date of authorisation: 27/09/1996, Revision: 46, Status: Authorised

Human medicines European public assessment report (EPAR): Zyprexa, olanzapine, Date of authorisation: 27/09/1996, Revision: 46, Status: Authorised

Jun 6, 2025 - 09:40
 0
Human medicines European public assessment report (EPAR): Zyprexa, olanzapine, Date of authorisation: 27/09/1996, Revision: 46, Status: Authorised
Human medicines European public assessment report (EPAR): Zyprexa, olanzapine, Date of authorisation: 27/09/1996, Revision: 46, Status: Authorised
Read More

Tags:

Previous Article

Opinion/decision on a Paediatric investigation plan (PIP): Piqray, Alpelisib, de...

Next Article

Embrace Poland and the Baltic States for Embracing Anti-Personnel Mines

Related Posts

Committee for Medicinal Products for Human Use (CHMP): 19-22 May 2025, European Medicines Agency, Amsterdam, the Netherlands, from 19 May 2025 to 22 May 2025

Committee for Medicinal Products for Human Use (CHMP): ...

May 19, 2025  0

Timetable: Type II variation and worksharing applicatio...

May 23, 2025  0

EMA workshop on primary efficacy endpoints for antivirals and monoclonal antibodies intended for the treatment of COVID-19 and influenza, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 5 June 2025, 13:00 (CEST) to 6 June 2025, 17:00 (CEST)

EMA workshop on primary efficacy endpoints for antivira...

May 13, 2025  0